Benorilate
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | N02BA10 (WHO) |
Identifiers | |
| |
CAS Number | 5003-48-5 N |
PubChem (CID) | 21102 |
ChemSpider | 19846 N |
UNII | W1QX9DV96G Y |
ChEMBL | CHEMBL162036 N |
Chemical and physical data | |
Formula | C17H15NO5 |
Molar mass | 313.305 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
NY (what is this?) (verify) |
Benorilate (INN), or benorylate, is an ester-linked codrug of aspirin with paracetamol. It is used as an anti-inflammatory and antipyretic medication. In the treatment of childhood fever, it has been shown to be inferior to paracetamol and aspirin taken separately. In addition, because it is converted to aspirin, benorylate is not recommended in children due to concerns about Reye syndrome.[1]
References
- ↑ Simila S, Keinanen S, Kouvalainen K.Oral antipyretic therapy: evaluation of benorylate, an ester of acetylsalicylic acid and paracetamol. Eur J Pediatr. 1975 Dec 9;121(1):15-20. PMID 2478
Opioids | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paracetamol-type |
| ||||||||||||||||||||||||||||||
NSAIDs |
| ||||||||||||||||||||||||||||||
Cannabinoids | |||||||||||||||||||||||||||||||
Ion channel modulators |
| ||||||||||||||||||||||||||||||
Myorelaxants | |||||||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||||||
|
Pyrazolones / Pyrazolidines | |
---|---|
Salicylates | |
Acetic acid derivatives and related substances | |
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) | |
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.